Genscript Biotech marginally expands issued share base after option exercise

Bulletin Express05-06

Hong Kong-listed Genscript Biotech Corporation reported that 91,000 new ordinary shares were issued in April 2026 through the exercise of employee share options. The transaction raised HKD 0.44 million and increased the total issued share count by 0.004 % to 2.19 billion shares.

The additional shares stemmed from the Post-IPO Share Option Scheme. After the exercise, 25.33 million options remain outstanding, while a further 202.74 million shares could still be issued under the scheme.

Authorised capital was unchanged at 5.00 billion ordinary shares with a par value of USD 0.001, equivalent to USD 5.00 million in registered share capital.

The company held no treasury shares and confirmed that the public float continued to meet the Hong Kong Stock Exchange’s 25 % minimum requirement. No warrants, convertible securities, or other equity instruments were outstanding or issued during the month.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1102483979?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-06 17:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1102483979","market":"us","top_or_hot":-1,"title":"Genscript Biotech marginally expands issued share base after option exercise","media":"Bulletin Express","content":"<p>Hong Kong-listed Genscript Biotech Corporation reported that 91,000 new ordinary shares were issued in April 2026 through the exercise of employee share options. The transaction raised HKD 0.44 million and increased the total issued share count by 0.004 % to 2.19 billion shares.</p>\n<p>The additional shares stemmed from the Post-IPO Share Option Scheme. After the exercise, 25.33 million options remain outstanding, while a further 202.74 million shares could still be issued under the scheme.</p>\n<p>Authorised capital was unchanged at 5.00 billion ordinary shares with a par value of USD 0.001, equivalent to USD 5.00 million in registered share capital.</p>\n<p>The company held no treasury shares and confirmed that the public float continued to meet the Hong Kong Stock Exchange’s 25 % minimum requirement. No warrants, convertible securities, or other equity instruments were outstanding or issued during the month.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Genscript Biotech marginally expands issued share base after option exercise</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGenscript Biotech marginally expands issued share base after option exercise\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-06 17:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hong Kong-listed Genscript Biotech Corporation reported that 91,000 new ordinary shares were issued in April 2026 through the exercise of employee share options. The transaction raised HKD 0.44 million and increased the total issued share count by 0.004 % to 2.19 billion shares.</p>\n<p>The additional shares stemmed from the Post-IPO Share Option Scheme. After the exercise, 25.33 million options remain outstanding, while a further 202.74 million shares could still be issued under the scheme.</p>\n<p>Authorised capital was unchanged at 5.00 billion ordinary shares with a par value of USD 0.001, equivalent to USD 5.00 million in registered share capital.</p>\n<p>The company held no treasury shares and confirmed that the public float continued to meet the Hong Kong Stock Exchange’s 25 % minimum requirement. No warrants, convertible securities, or other equity instruments were outstanding or issued during the month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01548","symbol_name":"金斯瑞生物科技","start_time":0,"source_url":"","article_id":"1102483979","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1102483979","pubTimestamp":1778058377,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hong Kong-listed Genscript Biotech Corporation reported that 91,000 new ordinary shares were issued in April 2026 through the exercise of employee share options. The transaction raised HKD 0.44...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01548":"金斯瑞生物科技"},"translate_title":"金斯瑞生物科技行使期权后小幅扩大已发行股份基础","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01548":1},"content_text":"Hong Kong-listed Genscript Biotech Corporation reported that 91,000 new ordinary shares were issued in April 2026 through the exercise of employee share options. The transaction raised HKD 0.44 million and increased the total issued share count by 0.004 % to 2.19 billion shares.\nThe additional shares stemmed from the Post-IPO Share Option Scheme. After the exercise, 25.33 million options remain outstanding, while a further 202.74 million shares could still be issued under the scheme.\nAuthorised capital was unchanged at 5.00 billion ordinary shares with a par value of USD 0.001, equivalent to USD 5.00 million in registered share capital.\nThe company held no treasury shares and confirmed that the public float continued to meet the Hong Kong Stock Exchange’s 25 % minimum requirement. No warrants, convertible securities, or other equity instruments were outstanding or issued during the month.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1102483979","isCrawlerRequest":true}